Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
What Is PT-141 and How Does It Work
Because the current trial was an open-label, non-randomized test, it would be critical to conduct follow-up studies using a blinded, placebo-controlled design
Phase 2 Type 2 Diabetes (Oral + Subcutaneous) Published: November 2025 Participants: 448 adults with T2D on metformin SGLT2i Duration: Up to 36 weeks Results: - Once-weekly subcutaneous amycretin: up to 14.5% weight loss (vs
S1A) and from 69 to 94% in males (Additional File 2: Fig
US$ 28.39
US$ 25.67
US$ 27.98
.png)
US$ 23.47
US$ 20.29
US$ 21.36
US$ 27.03
US$ 23.34
US$ 26.50
US$ 26.94
US$ 28.41
